tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Cash flow

Compare
834 Followers

VistaGen Therapeutics Cash Flow

VTGN's free cash flow for Q4 2025 was $-10.15M. For the 2025 fiscal year, VTGN's free cash flow was decreased by $-16.41M and operating cash flow was $-10.06M. See a summary of the company’s cash flow.
Cash Flow
Mar 25Mar 24Mar 23Mar 22Mar 21
Operating Cash Flow
$ -42.10M$ -25.81M$ -49.72M$ -45.26M$ -12.07M
Investing Cash Flow
$ -13.15M$ -61.00K$ -740.30K$ -200.40K$ -275.40K
Financing Cash Flow
$ 3.21M$ 128.40M$ -1.04M$ 10.48M$ 114.10M
End Cash Position
$ 67.13M$ 119.17M$ 16.64M$ 68.14M$ 103.11M
Free Cash Flow
$ -42.29M$ -25.87M$ -49.93M$ -45.46M$ -12.35M
Currency in USD

VistaGen Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis